Nationwide Fund Advisors Rigel Pharmaceuticals Inc Transaction History

Nationwide Fund Advisors

  • $1.26 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 01, 2018
SELL
$3.23 - $4.3 $765,245 - $1.02 Million
-236,918 Closed
0 $0
Q3 2017

Oct 23, 2017
SELL
$2.18 - $2.57 $23,415 - $27,604
-10,741 Reduced 4.34%
236,918 $602,000
Q2 2017

Aug 10, 2017
BUY
N/A
247,659
247,659 $676,000

Others Institutions Holding RIGL

# of Institutions
10
Shares Held
345K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.61B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Nationwide Fund Advisors Portfolio

Follow Nationwide Fund Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Nationwide Fund Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email